AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| MA1 | Ann: Daily share buy-back notice - Appendix 3E | 24/04/18 | 0 | 26 | |||
|
|||||||
| MA1 | Ann: Daily share buy-back notice - Appendix 3E | 23/04/18 | 0 | 33 | |||
|
|||||||
| MA1 | Ann: Daily share buy-back notice - Appendix 3E | 20/04/18 | 0 | 40 | |||
|
|||||||
| MA1 | Ann: Daily share buy-back notice - Appendix 3E | 19/04/18 | 0 | 38 | |||
|
|||||||
| MA1 | Ann: Change of Auditor | 18/04/18 | 0 | 35 | |||
|
|||||||
| MA1 | Ann: Daily share buy-back notice - Appendix 3E | 18/04/18 | 0 | 29 | |||
|
|||||||
| MA1 | Ann: Daily share buy-back notice - Appendix 3E | 17/04/18 | 0 | 35 | |||
|
|||||||
| MA1 | Ann: NTA - March 2018 | 13/04/18 | 0 | 53 | |||
|
|||||||
See All Discussions
ASX News